Anticipated Impact of Generic Imatinib Market Entry on the Costs of Tyrosine Kinase Inhibitors

Por Bloudek, Lisa M., Makenbaeva, Dinara, Eaddy, Michael
Publicado no Am Health Drug Benefits (2015)

CDR State Transition Probabilities in Alzheimer's Disease with and without Cholinesterase Inhibitor Intervention in an Observational Cohort

Por Bloudek, Lisa M., Spackman, D. Eldon, Veenstra, David L., Sullivan, Sean D.
Publicado em 2011

The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients

Por Rendas-Baum, Regina, Bloudek, Lisa M., Maglinte, Gregory A., Varon, Sepideh F.
Publicado em 2012

Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine

Por Rothrock, John F, Bloudek, Lisa M, Houle, Timothy T, Andress-Rothrock, Diane, Varon, Sepideh F
Publicado no Headache (2014)

Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine

Por Rendas-Baum, Regina, Yang, Min, Varon, Sepideh F, Bloudek, Lisa M, DeGryse, Ronald E, Kosinski, Mark
Publicado no Health Qual Life Outcomes (2014)

Headache-related health resource utilisation in chronic and episodic migraine across six countries

Por Sanderson, Joanna C, Devine, Emily B, Lipton, Richard B, Bloudek, Lisa M, Varon, Sepideh F, Blumenfeld, Andrew M, Goadsby, Peter J, Buse, Dawn C, Sullivan, Sean D
Publicado em 2013